Lois Wurzel, MD | |
77 Bayberry Hill Rd, Avon, CT 06001-2800 | |
(860) 558-6527 | |
(860) 678-8895 |
Full Name | Lois Wurzel |
---|---|
Gender | Female |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 77 Bayberry Hill Rd, Avon, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538452594 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 025894 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lois Wurzel, MD 77 Bayberry Hill Rd, Avon, CT 06001-2800 Ph: (860) 676-1981 | Lois Wurzel, MD 77 Bayberry Hill Rd, Avon, CT 06001-2800 Ph: (860) 558-6527 |
News Archive
A new study finds that survivors of hematopoietic stem cell transplant, an aggressive treatment for blood cancers, benefited from a two-part peer support process the authors call expressive helping.
FIJIĀ® Water, the country's leading premium imported bottled water, announced today that it has acquired the award-winning JUSTIN Vineyards & Winery in Paso Robles, California. Known for its Bordeaux-style blends and single varietals, combining Old World tradition with New World techniques, JUSTIN Vineyards & Winery is a critically-acclaimed, world class premium wine brand that FIJI Water and its parent company, Roll International, are proud to add to their portfolio.
Scientists are untangling how the tiniest pollution particles - which we take in with every breath we breathe - affect our health, making people more vulnerable to cardiovascular and respiratory problems.
Jenny Yang, a Regents' Professor of chemistry at Georgia State University and the associate director of the Center for Diagnostics and Therapeutics, has been selected as a National Academy of Inventors (NAI) Fellow, the academy board announced on Tuesday.
At a roundtable organized by the Coalition for Innovation Employment and Development, the U.S.-India Business Council's 'Coalition for Healthy India' released the findings of its report on "The Value of Incremental Pharmaceutical Innovation: Benefits for Indian Patients and Indian Business". The report highlights and substantiates the impact of restrictive policies in India, with respect to medical and pharmaceutical innovation.
› Verified 8 days ago